REGENXBIO, Inc. (RGNX)

9.21 +0.17 (+1.88%) USD  |  NASDAQ  |  Mar 02, 11:04
More

REGENXBIO Reconciled Depreciation (Quarterly)

Reconciled Depreciation (Quarterly) Chart

View Reconciled Depreciation (Quarterly) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Reconciled Depreciation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Reconciled Depreciation (Quarterly) Range, Past 5 Years

View Reconciled Depreciation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Reconciled Depreciation (Quarterly) Benchmarks

View Reconciled Depreciation (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Omeros Corp. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
CytomX Therapeutics, Inc. Upgrade